Outcomes
±
As a primary outcome, the anti-S serologic response at four weeks (± seven days) after the booster dose was compared between the two intervention groups by measuring IgG Immune status ratio (ISR), and positivity rate, defined as an increase in the ISR to the cut-off point for a positive result in the semiquantitative test, as described previously (